These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 20204916)

  • 21. Assessing treatment integrity in cognitive-behavioral therapy: comparing session segments with entire sessions.
    Weck F; Grikscheit F; Höfling V; Stangier U
    Behav Ther; 2014 Jul; 45(4):541-52. PubMed ID: 24912466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Baseline patterns of substance use disorder severity and depression and anxiety symptoms moderate the efficacy of mindfulness-based relapse prevention.
    Roos CR; Bowen S; Witkiewitz K
    J Consult Clin Psychol; 2017 Nov; 85(11):1041-1051. PubMed ID: 29083220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mindfulness-based relapse prevention for substance craving.
    Witkiewitz K; Bowen S; Douglas H; Hsu SH
    Addict Behav; 2013 Feb; 38(2):1563-1571. PubMed ID: 22534451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mindfulness-based treatment to prevent addictive behavior relapse: theoretical models and hypothesized mechanisms of change.
    Witkiewitz K; Bowen S; Harrop EN; Douglas H; Enkema M; Sedgwick C
    Subst Use Misuse; 2014 Apr; 49(5):513-24. PubMed ID: 24611847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mindfulness-based relapse prevention for cannabis regular users: Preliminary outcomes of a randomized clinical trial.
    Schneegans A; Bourgognon F; Albuisson E; Schwan R; Arfa M; Polli L; Moulard M; Laprévote V; Schwitzer T
    Encephale; 2022 Jun; 48(3):241-246. PubMed ID: 34092381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mindfulness-Based Relapse Prevention in a Jail Drug Treatment Program.
    Lyons T; Womack VY; Cantrell WD; Kenemore T
    Subst Use Misuse; 2019; 54(1):57-64. PubMed ID: 30409061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Mindfulness-Oriented Recovery Enhancement Fidelity Measure (MORE-FM): Development and Validation of a New Tool to Assess Therapist Adherence and Competence.
    Hanley AW; Garland EL
    J Evid Based Soc Work (2019); 2021; 18(3):308-322. PubMed ID: 33164711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparing Effectiveness of Mindfulness-Based Relapse Prevention with Treatment as Usual on Impulsivity and Relapse for Methadone-Treated Patients: A Randomized Clinical Trial.
    Yaghubi M; Zargar F; Akbari H
    Addict Health; 2017 Jul; 9(3):156-165. PubMed ID: 29657696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patient characteristics and variability in adherence and competence in cognitive-behavioral therapy for panic disorder.
    Boswell JF; Gallagher MW; Sauer-Zavala SE; Bullis J; Gorman JM; Shear MK; Woods S; Barlow DH
    J Consult Clin Psychol; 2013 Jun; 81(3):443-54. PubMed ID: 23339537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized trial comparing mindfulness-based relapse prevention with relapse prevention for women offenders at a residential addiction treatment center.
    Witkiewitz K; Warner K; Sully B; Barricks A; Stauffer C; Thompson BL; Luoma JB
    Subst Use Misuse; 2014 Apr; 49(5):536-46. PubMed ID: 24611849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A pilot study of mindfulness-based relapse prevention for compulsive sexual behaviour disorder.
    Holas P; Draps M; Kowalewska E; Lewczuk K; Gola M
    J Behav Addict; 2020 Nov; 9(4):1088-1092. PubMed ID: 33216012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparing the Efficacy of Mindfulness-Based Relapse Prevention Versus Relapse Prevention for Alcohol Use Disorder: A Randomized Control Trial.
    Skrzynski CJ; Karoly H; Ellingson JM; Hagerty SL; Bryan AD; Hutchison KE
    J Stud Alcohol Drugs; 2023 Jul; 84(4):560-569. PubMed ID: 36971735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mindfulness practice predicts interleukin-6 responses to a mindfulness-based alcohol relapse prevention intervention.
    McClintock AS; Goldberg SB; Coe CL; Zgierska AE
    J Subst Abuse Treat; 2019 Oct; 105():57-63. PubMed ID: 31443893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The methods and baseline characteristics of a multi-site randomized controlled trial evaluating mindfulness-based relapse prevention in conjunction with peer support to improve adherence to medications for opioid use disorders.
    Mumba MN; Mugoya GT; Allen RS; Glenn AL; Richman J; Ghera A; Butler A; Rogers B; Granger TA; Davis LL
    Front Psychiatry; 2024; 15():1330672. PubMed ID: 38974917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rationale, design, and implementation of a clinical trial of a mindfulness-based relapse prevention protocol for the treatment of women with comorbid post traumatic stress disorder and substance use disorder.
    Vrana C; Killeen T; Brant V; Mastrogiovanni J; Baker NL
    Contemp Clin Trials; 2017 Oct; 61():108-114. PubMed ID: 28765006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in inter-rater reliability and accuracy for a treatment adherence scale.
    Wu SM; Whiteside U; Neighbors C
    Cogn Behav Ther; 2007; 36(4):230-9. PubMed ID: 18049948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Language-based measures of mindfulness: initial validity and clinical utility.
    Collins SE; Chawla N; Hsu SH; Grow J; Otto JM; Marlatt GA
    Psychol Addict Behav; 2009 Dec; 23(4):743-9. PubMed ID: 20025383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Examining psychometric properties of distress tolerance and its moderation of mindfulness-based relapse prevention effects on alcohol and other drug use outcomes.
    Hsu SH; Collins SE; Marlatt GA
    Addict Behav; 2013 Mar; 38(3):1852-8. PubMed ID: 23266526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mindfulness practice moderates the relationship between craving and substance use in a clinical sample.
    Enkema MC; Bowen S
    Drug Alcohol Depend; 2017 Oct; 179():1-7. PubMed ID: 28734167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive validity of an observer-rated adherence protocol for multisystemic therapy with juvenile drug offenders.
    Gillespie ML; Huey SJ; Cunningham PB
    J Subst Abuse Treat; 2017 May; 76():1-10. PubMed ID: 28340901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.